The Role of Bilateral Superior Laryngeal Nerve Block in Managing Refractory Chronic Cough.
laryngeal hypersensitivity
laryngology
refractory chronic cough
superior laryngeal nerve block
Journal
The Laryngoscope
ISSN: 1531-4995
Titre abrégé: Laryngoscope
Pays: United States
ID NLM: 8607378
Informations de publication
Date de publication:
Apr 2024
Apr 2024
Historique:
revised:
20
07
2023
received:
03
04
2023
accepted:
05
09
2023
medline:
18
3
2024
pubmed:
26
9
2023
entrez:
26
9
2023
Statut:
ppublish
Résumé
The aim was to investigate the utilization and efficacy of bilateral superior laryngeal nerve block in patients with refractory chronic cough. A retrospective chart review of 164 patients with refractory chronic cough who underwent bilateral SLN block at a single institution between November 2018 and September 2022 was performed. Demographics, comorbidities, and patient-reported outcomes including pre- and postinjection Leicester Cough Questionnaire (LCQ) scores were collected and analyzed. The cohort underwent an average of 2.97 bilateral injections (range 1-22), containing either corticosteroid and local anesthetic or corticosteroid alone. Notably, 116 of 164 of patients reported an average of 67.3% reduction in their symptoms, with the treatment effect lasting 7.60 weeks on average. The average pre- and postinjection LCQ scores were 9.70 and 13.82, respectively. A lower LCQ score represents a greater impairment of health status due to cough, and the minimum important change is 1.3 points between questionnaires. The average improvement on LCQ following bilateral SLN block was 4.11 points for this cohort. The use of in-office bilateral SLN block is an effective treatment that can be used alone or in conjunction with oral medications for the treatment of refractory chronic cough. 4 Laryngoscope, 134:1773-1777, 2024.
Substances chimiques
Adrenal Cortex Hormones
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1773-1777Informations de copyright
© 2023 The Authors. The Laryngoscope published by Wiley Periodicals LLC on behalf of The American Laryngological, Rhinological and Otological Society, Inc.
Références
Song W-J, Chang Y-S, Faruqi S, et al. The global epidemiology of chronic cough in adults: a systematic review and meta-analysis. Eur Respir J. 2015;45(5):1479-1481.
Altman KW, Noordzij JP, Rosen CA, Cohen S, Sulica L. Neurogenic cough. Laryngoscope. 2015;125:1675-1681.
Chung KF. Approach to chronic cough: the neuropathic basis for cough hypersensitivity syndrome. J Thorac Dis. 2014;6(Suppl 7):S699-S707. https://doi.org/10.3978/j.issn.2072-1439.2014.08.41.
Birring SS, Floyd S, Reilly CC, Cho PSP. Physiotherapy and speech and language therapy intervention for chronic cough. Pulm Pharmacol Ther. 2017;47:84-87. https://doi.org/10.1016/J.PUPT.2017.04.001.
Chu MW, Lieser JD, Sinacori JT. Use of botulinum toxin type a for chronic cough: a neuropathic model. Arch Otolaryngol Head Neck Surg. 2010;136(5):447-452. https://doi.org/10.1001/archoto.2010.59.
Simpson CB, Tibbetts KM, Loochtan MJ, Dominguez LM. Treatment of chronic neurogenic cough with in-office superior laryngeal nerve block. Laryngoscope. 2018;128(8):1898-1903.
Dhillon VK. Superior laryngeal nerve block for neurogenic cough: a case series. Laryngoscope Investig Otolaryngol. 2019;4(4):410-413. https://doi.org/10.1002/lio2.292.
Tipton CB, O'Rourke AK. Efficacy of superior laryngeal nerve block for the treatment of neurogenic cough: a retrospective review. Clin Otolaryngol. 2022;47(1):187-191.
The Voice Handicap Index (VHI). Development and Validation. Barbara H. Jacobson, Alex Johnson, Cynthia Grywalski, Alice Silbergleit, Gary Jaconsen, Michael S. Benninger. American Journal of Speech-Language Pathology, Vol 6(3), 66-70. The Voice Handicap Index is reprinted with permission from all authors and ASHA. Copyright 1997-2001 American Speech-Language-Hearing Association. 1997.
Birring SS, Prudon B, Carr AJ, Singh SJ, Morgan MD, Pavord ID. Development of a symptom specific health status measure for patients with chronic cough: Leicester cough questionnaire (LCQ). Thorax. 2003;58(4):339-343. https://doi.org/10.1136/thorax.58.4.339 PMID: 12668799; PMCID: PMC1746649.
García-Vicente P, Rodríguez-Valiente A, Górriz Gil C, et al. Chronic cough in post-COVID syndrome: laryngeal electromyography findings in vagus nerve neuropathy. PloS One. 2023;18(3):e0283758. https://doi.org/10.1371/journal.pone.0283758.
Benyamin RM, Manchikanti L, Parr AT, et al. The effectiveness of lumbar interlaminar epidural injections in managing chronic low back and lower extremity pain. Pain Physician. 2012;15(4):E363-E404. PMID: 22828691.
Manchikanti L, Knezevic NN, Boswell MV, Kaye AD, Hirsch JA. Epidural injections for lumbar radiculopathy and spinal stenosis: a comparative systematic review and meta-analysis. Pain Physician. 2016;19(3):E365-E410. PMID: 27008296.
Shanthanna H, Busse JW, Thabane L, et al. Local anesthetic injections with or without steroid for chronic non-cancer pain: a protocol for a systematic review and meta-analysis of randomized controlled trials. Syst Rev. 2016;5:18. https://doi.org/10.1186/s13643-016-0190-z PMID: 26831725; PMCID: PMC4736179.
Zhu B, Zhou X, Zhou Q, Wang H, Wang S, Luo K. Intra-venous lidocaine to relieve neuropathic pain: a systematic review and meta-analysis. Front Neurol. 2019;10:954. https://doi.org/10.3389/fneur.2019.00954 PMID: 31620064; PMCID: PMC6759769.